| abstract |
Compounds of formula (I) and formula (II), wherein R 2 , R 4 , A, B, D, W, X, Y and Z are as defined herein, are useful as CGRP receptor antagonists and are therefore useful in the treatment or prophylaxis of Conditions associated with CGRP, such as headaches, migraines, and migraines. The present invention also relates to pharmaceutical compositions containing these compounds, and the use of these compounds and compositions in the prevention or treatment of such CGRP-related diseases. |